Search

everythinglearnresearchcommunity

for

Search:↓

Scarring alopecia is linked to higher rates of vitamin D deficiency, metabolic issues, mental health problems, thyroid disease, and other health conditions.

Minoxidil, a hair loss treatment, may help nails grow faster.

Iron supplements may reverse premature graying in iron-deficient individuals; ingrown nails are common in diabetics with certain risk factors; topical finasteride may reduce scalp DHT as effectively as oral finasteride; monilethrix treatment is challenging but some medications can help.

A woman was allergic to 5% minoxidil, with stronger reactions to higher concentrations.

Both genes and environmental factors like chemicals may contribute to the increase in hypospadias, but the exact causes are still unclear.

Prostaglandin D2 increases testosterone production in skin cells through a process involving reactive oxygen species, which could be a new target for treating hair loss and other skin conditions driven by testosterone.

Higher dihydrotestosterone may be linked to more inflammation in COVID-19 patients with low testosterone.

Women with AGA have more androstenedione and dihydrotestosterone, less copper and zinc; copper imbalance affects AGA; treatment improves hormones and minerals.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Hair sensitivity to androgens is partly controlled by specific enzyme expressions in different hair areas.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

Some men with early hair loss may have a male version of PCOS, affecting hormones and increasing health risks.

Androstanediol glucuronide is a reliable marker for hirsutism in women.

Surgery to lower high testosterone in postmenopausal women with certain ovarian tumors doesn't significantly affect their metabolism.

Male pattern baldness involves hormone-related hair thinning, shorter hair, and inflammation.

The treatment reduced hair growth and testosterone in women with excess hair and had some effects on stress responses.

Androgens like testosterone affect skin health and can lead to conditions such as acne and hair loss, with various treatments available.

Protease Nexin-1 is found in human hair growth cells and is affected by male hormones.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

Too much androgen can cause hair loss; finasteride may help.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Finasteride and minoxidil are effective FDA-approved treatments for androgenetic alopecia.

Androgens, like DHT, affect hair growth and treatments like finasteride may help.

Polycystic Ovary Syndrome should be seen mainly as a condition of excess male hormones, with a focus on this in its definition.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Creating stronger blockers for skin enzymes might lead to better treatment for conditions like acne and excessive hair growth.

Effective treatments for male pattern baldness include oral finasteride and topical minoxidil, while topical minoxidil is best for female pattern baldness.

Inflammation may be linked to hair loss, and targeting specific enzymes could help treat it.

Women with PCOS have higher androgen levels that decrease with age but are still higher than in women without PCOS.